Select Your Region
- Manufacturer: Evonik Corporation
- Product Line: LACTEL® Polymers
- Product: LACTEL® PLGE Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
LACTEL® 50:50 DL-PLGE, IV 0.76-0.94
LACTEL® 50:50 DL-PLGE, IV 0.76-0.94 is an ester-terminated lactide-glycolide-containing copolymer (CAS No. 26780-50-7) with an inherent viscosity of 0.76─0.94 dL/g in HFIP and a degradation time of 3 months max.
Quantity
Documents
Specifications
Physical state: Solid
Form: Granules
Color: White to light tan
Inherent viscosity (IV) dL/g: 0.76─0.94 (in HFIP)
Degradation time: <3 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS No. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
- Manufacturer: Evonik Corporation
- Product Line: LACTEL® Polymers
- Product: LACTEL® PLGE Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
Manufacturer
Product Line
Product
Industries
Authorized Countries
Canada
United States
Overview
Evonik's LACTEL® 50:50 DL-PLGE, IV 0.76-0.94 is a versatile pellatized excipient polymer with an ester terminated lactide-glycolide base with a mol ratio of 50:50. Manufactured using a streamlined process to produce a cost-effective PLGA copolymer, Evonik's LACTEL® 50:50 DL-PLGE, IV 0.76-0.94 is non-solvent purified and formulated with no-added preservatives. It is commonly recommended for use in the formulation of long-acting injectable formulations in veterinary medicine and human generic drug formulations, exhibiting excellent compatibility with a range of pharmaceutical substance types, including peptides, proteins, nanoparticles, and microparticles.
Specifications
Physical state: Solid
Form: Granules
Color: White to light tan
Inherent viscosity (IV) dL/g: 0.76─0.94 (in HFIP)
Degradation time: <3 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS No. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
Features & Benefits
- 50:50 ratio of D,L-Lactide and Glycolide
- Ester end group
- 3-month degradation time
- Biodegradable
- Ideal for terminal sterilization
- Bioabsorbable excipient
- Suitable for use with small molecules, peptides, proteins, and other substances
- Non-GMO
- No added preservatives
- Cost effective
Applications
Human generic drug formulations
Long-acting injectable formulations
Price sensitive applications
veterinary medicine
Related Applications
Pharmaceuticals
Related Functions
Pharmaceuticals
ChemPoint is here to help
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States
